New biomarker for bone marrow cancer: Discovery suggests new ways of treating multiple myeloma
Thursday, December 13, 2012 - 11:30
in Health & Medicine
Singapore scientists have identified FAIM, a molecule that typically prevents cell death, as a potential biomarker to identify an incurable form of cancer in the bone marrow. Patients with this form of cancer usually do not get cured with current standard treatments such as chemotherapy and stem cell transplantation, with an average survival of only about four years.